cebranopadol (TRN-228) - Tris Pharma
ALLEVIATE-2: A Study of Cebranopadol for the Treatment of Acute Pain After Bunionectomy (clinicaltrials.gov) - Dec 13, 2024 - P3 | N=240 | Recruiting | Sponsor: Tris Pharma, Inc. | Not yet recruiting ➔ Recruiting | Trial completion date: Dec 2024 ➔ Mar 2025 | Trial primary completion date: Nov 2024 ➔ Feb 2025 
Enrollment open • Trial completion date • Trial primary completion date • Pain
http://clinicaltrials.gov/ct2/show/NCT06423703
 
Dec 13, 2024
 
Prev Next